IL145580A0 - A modified release pharmaceutical composition comprising amoxycillin and potassium clavulanate - Google Patents

A modified release pharmaceutical composition comprising amoxycillin and potassium clavulanate

Info

Publication number
IL145580A0
IL145580A0 IL14558000A IL14558000A IL145580A0 IL 145580 A0 IL145580 A0 IL 145580A0 IL 14558000 A IL14558000 A IL 14558000A IL 14558000 A IL14558000 A IL 14558000A IL 145580 A0 IL145580 A0 IL 145580A0
Authority
IL
Israel
Prior art keywords
amoxycillin
pharmaceutical composition
modified release
release pharmaceutical
potassium clavulanate
Prior art date
Application number
IL14558000A
Other languages
English (en)
Original Assignee
Beecham Pharm Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27383840&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL145580(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Pharm Pte Ltd filed Critical Beecham Pharm Pte Ltd
Publication of IL145580A0 publication Critical patent/IL145580A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
IL14558000A 1999-04-13 2000-04-11 A modified release pharmaceutical composition comprising amoxycillin and potassium clavulanate IL145580A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US12907499P 1999-04-13 1999-04-13
US15072799P 1999-08-25 1999-08-25
US15981399P 1999-10-15 1999-10-15
PCT/IB2000/000992 WO2000061116A2 (en) 1999-04-13 2000-04-11 Pharmaceutical formulation comprising amoxycillin and clavulanate

Publications (1)

Publication Number Publication Date
IL145580A0 true IL145580A0 (en) 2002-11-10

Family

ID=27383840

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14558000A IL145580A0 (en) 1999-04-13 2000-04-11 A modified release pharmaceutical composition comprising amoxycillin and potassium clavulanate
IL145580A IL145580A (en) 1999-04-13 2001-09-24 Use of amoxicillin and potassium calvulant for the preparation of drugs for the treatment of bacterial infections and pharmaceutical preparations with coordinated release containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL145580A IL145580A (en) 1999-04-13 2001-09-24 Use of amoxicillin and potassium calvulant for the preparation of drugs for the treatment of bacterial infections and pharmaceutical preparations with coordinated release containing them

Country Status (45)

Country Link
EP (4) EP1044680B1 (pt)
JP (2) JP4880125B2 (pt)
KR (1) KR100634937B1 (pt)
CN (1) CN100382782C (pt)
AP (1) AP1806A (pt)
AR (1) AR031068A1 (pt)
AT (2) AT4327U1 (pt)
AU (1) AU767177B2 (pt)
BE (2) BE1013309A5 (pt)
BG (1) BG65006B1 (pt)
BR (1) BRPI0009719B8 (pt)
CA (1) CA2366304C (pt)
CO (1) CO5170471A1 (pt)
CZ (1) CZ298801B6 (pt)
DE (3) DE10017883A1 (pt)
DK (3) DK200000602A (pt)
DZ (1) DZ3150A1 (pt)
EA (1) EA004310B1 (pt)
ES (2) ES2202004T3 (pt)
FI (2) FI20000863A (pt)
FR (1) FR2792198A1 (pt)
GB (1) GB2351661B (pt)
GR (1) GR1003560B (pt)
HK (1) HK1032741A1 (pt)
HU (1) HU229097B1 (pt)
IE (1) IE20000271A1 (pt)
IL (2) IL145580A0 (pt)
IT (1) ITMI20000788A1 (pt)
MA (1) MA25352A1 (pt)
MX (1) MXPA01010377A (pt)
MY (1) MY119953A (pt)
NL (2) NL1014915C2 (pt)
NO (1) NO329694B1 (pt)
NZ (1) NZ514575A (pt)
OA (1) OA11926A (pt)
PE (1) PE20010053A1 (pt)
PL (1) PL197448B1 (pt)
PT (2) PT102450B (pt)
RO (1) RO120817B1 (pt)
SE (1) SE0001330L (pt)
SI (2) SI1044680T1 (pt)
SK (1) SK285140B6 (pt)
TR (1) TR200102963T2 (pt)
TW (1) TWI235067B (pt)
WO (1) WO2000061116A2 (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9407386D0 (en) 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
WO1997009042A1 (en) 1995-09-07 1997-03-13 Smithkline Beecham Corporation Pharmaceutical formulation
SE9802973D0 (sv) 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
EP1330236A2 (en) * 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
CA2452871C (en) 2001-07-06 2011-10-04 Endo Pharmaceuticals, Inc. Oxymorphone controlled release formulations
GB0117618D0 (en) * 2001-07-19 2001-09-12 Phoqus Ltd Pharmaceutical dosage form
US6863901B2 (en) 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
CA2480826C (fr) 2002-04-09 2012-02-07 Flamel Technologies Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
JP2005528383A (ja) * 2002-04-10 2005-09-22 ミラー，フレッド，エイチ． 多重相・複数コンパートメントカプセルシステム
US20050042289A1 (en) * 2003-04-29 2005-02-24 Yamanouchi Pharma Technologies, Inc. Tablets and methods for modified release of hydrophylic and other active agents
US8062672B2 (en) 2003-08-12 2011-11-22 Shionogi Inc. Antibiotic product, use and formulation thereof
EP1541129A1 (en) * 2003-12-12 2005-06-15 Cimex AG Pharmaceutical effervescent formulation comprising amoxycillin and clavulanic acid
US20070196396A1 (en) * 2004-02-11 2007-08-23 Rubicon Research Private Limited Controlled release pharmaceutical compositions with improved bioavailability
WO2005099672A1 (en) * 2004-04-13 2005-10-27 Ranbaxy Laboratories Limited A modified release pharmaceutical formulation comprising amoxicillin and clavulanate
EP1880716A1 (en) * 2006-07-19 2008-01-23 Sandoz AG Kit of parts comprising an acid labile and an acid resistant pharmaceutically active ingredient
EP2079453A1 (en) * 2006-10-10 2009-07-22 Penwest Pharmaceuticals Co. Robust sustained release formulations
TR200909787A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
TR201000687A1 (tr) 2010-01-29 2011-08-22 Bi̇lgi̇ç Mahmut Aktif madde olarak sefiksim ve klavulanik asit içeren efervesan formülasyonlar
TR201000686A1 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@
TR201000688A2 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
CA2981759C (en) 2015-04-07 2021-10-12 Church & Dwight Co., Inc. Multicomponent gummy compositions with soft core
CN109394718B (zh) * 2018-11-15 2021-04-27 石药集团中诺药业（石家庄）有限公司 一种阿莫西林分散片及其制备方法
CN110051637A (zh) * 2019-05-21 2019-07-26 葵花药业集团北京药物研究院有限公司 阿莫西林克拉维酸钾制剂及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0008905B1 (en) * 1978-09-06 1983-02-16 Beecham Group Plc Pharmaceutical compositions containing two beta-lactam derivatives
IL58461A0 (en) * 1978-10-27 1980-01-31 Beecham Group Ltd Intramammary compositions comprising a clavulanic acid salt
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
GB9007945D0 (en) * 1990-04-07 1990-06-06 Beecham Group Plc Pharmaceutical formulation
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
EP0680322B1 (en) * 1993-01-22 2000-07-05 Smithkline Beecham Plc Use of clavulanate and an antibacterial compound for the treatment of infections
GB9311030D0 (en) * 1993-05-28 1993-07-14 Smithkline Beecham Corp Pharmaceutical formulations
IL109770A0 (en) * 1993-05-29 1994-11-28 Smithkline Beecham Corp Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
GB9407386D0 (en) * 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
ITMI941169A1 (it) * 1994-06-06 1995-12-06 Smithkline Beecham Farma Formulazioni farmaceutiche
GB9416600D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
GB9416599D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
WO1997009042A1 (en) * 1995-09-07 1997-03-13 Smithkline Beecham Corporation Pharmaceutical formulation
GB9616536D0 (en) * 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
PL334976A1 (en) * 1997-02-14 2000-03-27 Smithkline Beecham Lab Pharmaceutic preparations containing amoxycyclin and clavulate
SK121099A3 (en) * 1997-03-11 2000-06-12 Almag Al Process and apparatus for coating metals
SE9700885D0 (sv) * 1997-03-12 1997-03-12 Astra Ab New pharmaceutical formulation
CN1251035A (zh) * 1997-03-25 2000-04-19 武田药品工业株式会社 胃肠粘膜粘附性药物组合物
JP3746901B2 (ja) * 1997-10-15 2006-02-22 ユニ・チャーム株式会社 開閉自在容器
GB9815532D0 (en) * 1998-07-17 1998-09-16 Lek Pharmaceutical & Cvhemical Pharmaceutical suspension formulation
GB9818927D0 (en) * 1998-08-28 1998-10-21 Smithkline Beecham Plc Pharmaceutical formulation
US6225304B1 (en) * 1999-02-17 2001-05-01 Pharmaceutical Solutions, Inc. Soluble forms of amoxicillin and treatment of animals

Also Published As

Publication number Publication date
JP2011256180A (ja) 2011-12-22
TR200102963T2 (tr) 2002-02-21
FI4823U1 (fi) 2001-02-16
SK285140B6 (sk) 2006-07-07
FIU20000164U0 (fi) 2000-04-11
BRPI0009719B8 (pt) 2021-05-25
BR0009719A (pt) 2002-01-08
BG104329A (en) 2001-11-30
BG65006B1 (bg) 2006-12-29
AT4327U1 (de) 2001-06-25
PE20010053A1 (es) 2001-03-10
ES2202004T3 (es) 2004-04-01
DK200000602A (da) 2000-10-14
NO329694B1 (no) 2010-12-06
EP1269996A1 (en) 2003-01-02
DK1044680T3 (da) 2003-09-29
DE20006626U1 (de) 2000-10-19
DK200000133U3 (da) 2000-07-28
IL145580A (en) 2007-05-15
AR031068A1 (es) 2003-09-10
WO2000061116A3 (en) 2001-02-01
EP1270005A2 (en) 2003-01-02
SK5342000A3 (en) 2000-11-07
SI1044680T1 (en) 2003-12-31
TWI235067B (en) 2005-07-01
FR2792198A1 (fr) 2000-10-20
RO120817B1 (ro) 2006-08-30
EP1270005A3 (en) 2006-05-17
ATE242629T1 (de) 2003-06-15
HK1032741A1 (en) 2001-08-03
PL339591A1 (en) 2000-10-23
MXPA01010377A (es) 2002-10-23
BE1012733A6 (fr) 2001-02-06
PT1044680E (pt) 2003-10-31
EA004310B1 (ru) 2004-02-26
SE0001330D0 (sv) 2000-04-11
KR100634937B1 (ko) 2006-10-17
ES2190692B1 (es) 2004-11-16
SE0001330L (sv) 2000-10-14
BR0009719B1 (pt) 2014-09-30
KR20020015312A (ko) 2002-02-27
GR1003560B (el) 2001-03-16
DE10017883A1 (de) 2000-10-26
NZ514575A (en) 2004-05-28
NO20001870L (no) 2000-10-16
DE60003255T2 (de) 2004-05-06
EP1269997A1 (en) 2003-01-02
MY119953A (en) 2005-08-30
JP2002541187A (ja) 2002-12-03
PT102450A (pt) 2001-02-01
DZ3150A1 (fr) 2000-10-19
BE1013309A5 (fr) 2001-11-06
NL1014915A1 (nl) 2000-10-16
AU767177B2 (en) 2003-11-06
SI20304A (sl) 2001-02-28
FI20000863A0 (fi) 2000-04-11
PL197448B1 (pl) 2008-03-31
ES2190692A1 (es) 2003-08-01
JP4880125B2 (ja) 2012-02-22
HU229097B1 (en) 2013-07-29
CN100382782C (zh) 2008-04-23
AP1806A (en) 2007-12-14
HU0001471D0 (en) 2000-06-28
GB0008923D0 (en) 2000-05-31
NL1014914C1 (nl) 2000-10-16
ITMI20000788A1 (it) 2001-10-11
PT102450B (pt) 2003-09-30
DE60003255D1 (de) 2003-07-17
GB2351661A (en) 2001-01-10
HUP0001471A3 (en) 2001-10-29
CN1382040A (zh) 2002-11-27
OA11926A (en) 2006-04-12
AU5702000A (en) 2000-11-14
CZ298801B6 (cs) 2008-02-06
EA200101075A1 (ru) 2002-04-25
IE20000271A1 (en) 2001-04-04
ITMI20000788A0 (it) 2000-04-11
CA2366304A1 (en) 2000-10-19
CZ20001311A3 (cs) 2000-11-15
NO20001870D0 (no) 2000-04-11
FI20000863A (fi) 2000-10-13
EP1044680B1 (en) 2003-06-11
HUP0001471A2 (en) 2001-03-28
MA25352A1 (fr) 2001-12-31
GB2351661B (en) 2001-10-10
CO5170471A1 (es) 2002-06-27
CA2366304C (en) 2004-06-29
AP2001002284A0 (en) 2001-12-31
NL1014915C2 (nl) 2001-02-12
EP1044680A1 (en) 2000-10-18
WO2000061116A2 (en) 2000-10-19

Similar Documents

Publication Publication Date Title
IL145580A0 (en) A modified release pharmaceutical composition comprising amoxycillin and potassium clavulanate
IL145581A0 (en) A modified release pharmaceutical composition comprising amoxycillin
IL131201A (en) Pharmaceutical formulations comprising amoxycillin and clavulanate
EP1189895B8 (en) Thiazole and oxazole derivatives and their pharmaceutical use
HK1040995A1 (zh) 二氧喹啉化合物及其醫藥用途
AU5335698A (en) Pharmaceutical formulations with delayed drug release
AU2276801A (en) Extended release oral dosage composition
AUPQ969800A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU6089200A (en) Rapid immediate release oral dosage form
AU2001264313A1 (en) Pyrazolopyridine compounds and use thereof as drugs
PL354168A1 (en) Pharmaceutical composition of nateglinide and another antidiabetcagent
AU5326100A (en) Pharmaceutical compositions and methods for use
AU4344000A (en) Drug releasing elastic band and method
AU1887401A (en) Medicinal composition
AU2002218502A1 (en) Lactam compounds and medicinal use thereof
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU5272399A (en) Non-porphyrin compound for use as a diagnosticum and/or pharmaceutical
AU1912501A (en) Water-soluble powders for oral solution and use thereof
AU1053501A (en) Polyazanaphthalene compound and medicinal use thereof
AUPQ462299A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU2205401A (en) Pharmaceutical formulations comprising sodium amoxycillin and potassium clavulanate
AU5483600A (en) Pharmaceutical materials and methods for their preparation and use
AU5974100A (en) 6-carboxyphenyldihydropyridazinone derivatives and use thereof
IL123788A0 (en) (+)-O-demethyltramadol for use as a pain-killing drug for oral application
AU5343498A (en) Thiophene compounds and medicinal use thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed